THE FUTURE OF MEDICINE IS PREDICTIVE & PREVENTATIVE
A predictive MDR CE class 2a medical device for preventive cardiovascular medicine
IMAGEENS has developed Europe’s first clinically-validated software as a medical device enabling the measurement of biomarkers linked to patients’ cardiovascular risk and cardiovascular aging. Our software as a medical device has successfully received the notoriously challenging class 2a approval under the EU’s new Medical Device Regulation (EU MDR).
ArtFun+
Enabling the measurement of predictive biomarkers
linked to cardiovascular risk & aging
Based on a robust, clinically
validated platform
We share our knowledge & approach with leading healthcare institutions to build more Predictive Clinical Decision AI
Our mission is to help physicians make better clinical decisions for their patients by making the most of their imaging data. By working with leading healthcare institutions, we:
1
MEASURE PREDICTIVE BIOMARKERS
Precisely characterise patients’ cardiovascular system, to help inform clinical decisions and evaluate drugs’ efficacy
2
CREATE STRUCTURED IMAGING DATABASES FOR AI-TRAINING
Clean & prepare our partners’ databases to make them ready for AI-training
3
BUILD CLINICAL DECISION AI
Using our biomarkers & the structured data, build AI clinical decision tools to predict patients’ outcomes and improve clinical decisions
We partner with
We’ve been awarded by
Check out our news
March 31, 2021
L’AP-HP et IMAGEENS créent un modèle de collaboration pour la structuration et la valorisation des données du soin